Treatment Guidelines


 
Effective October 2015, International Lyme and Associated Disease Society (ILADS) is proud to announce that a summary of their guidelines is now available on the National Guideline Clearinghouse website.  

The National Guideline Clearinghouse (NGC), a federal database that provides treatment information to health care professionals and insurance companies, is an initiative of the Agency for Healthcare Research and Quality (AHRQ), under the umbrella of the U.S. Department of Health and Human Services. In June 2014, NGC adopted the definition of a clinical practice guideline developed by the Institute of Medicine (IOM) and revised its inclusion criteria to more closely align with this definition. Guidelines must now satisfy these criteria to be represented on NGC. ILADS’s peer reviewed guidelines were accepted to be summarized on the NGC website because they met the revised inclusion criteria.
ILADS is the first organization to issue guidelines on Lyme disease that were developed in accordance with the IOM standards. The document provides a detailed review of the pertinent medical literature and contains the first set recommendations for Lyme disease based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. This rigorous review format is also used by many other well-respected medical organizations including the World Health Organization (WHO), the American College of Physicians, and the National Institute for Health and Clinical Excellence (NICE) in the UK. ILADS guidelines are the only Lyme disease guidelines that included a patient from the Lyme community as an author or as a member of the guidelines development panel.

In February 2016, the National Guidelines Clearinghouse removed the Infectious Disease Society of America (IDSA)'s Lyme disease treatment guidelines from its website for failure to comply with regulations that require treatment guidelines to be reviewed and updated every 5 years. After several notifications and failure to comply, the IDSA's outdated treatment guidelines were removed from the federal database. No updates hvae been submitted at this time.  For more information about this, please visit: https://www.lymedisease.org/idsa-guidelines-removed-ngc/